| Year |
Citation |
Score |
| 2022 |
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Herczeg A, Türk D, Hegedűs Z, Svajda L, Rásó E, Ladányi A, Csikó KG, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer. Cancers. 14. PMID 35626010 DOI: 10.3390/cancers14102407 |
0.579 |
|
| 2021 |
Nelhűbel GA, Cserepes M, Szabó B, Türk D, Kárpáti A, Kenessey I, Rásó E, Barbai T, Hegedűs Z, László V, Szokol B, Dobos J, Őrfi L, Tóvári J. EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas. Pathology Oncology Research : Por. 27: 620256. PMID 34257586 DOI: 10.3389/pore.2021.620256 |
0.615 |
|
| 2021 |
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Surguta SE, Rásó E, Ladányi A, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. [Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC]. Magyar Onkologia. 65: 188-195. PMID 34081766 |
0.588 |
|
| 2020 |
Uhlyarik A, Piurko V, Papai Z, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Timar J. EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy. Cancers. 12. PMID 32155907 DOI: 10.3390/Cancers12030614 |
0.416 |
|
| 2019 |
Uhlyarik A, Piurko V, Vizkeleti L, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Tímár J. EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy. Pathology Oncology Research : Por. PMID 30612313 DOI: 10.1007/S12253-018-00572-2 |
0.393 |
|
| 2018 |
Imrédi E, Liszkay G, Kenessey I, Plotár V, Gödény M, Tóth B, Fedorcsák I, Tímár J. Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma. Pathology Oncology Research : Por. PMID 30378011 DOI: 10.1007/S12253-018-0513-6 |
0.362 |
|
| 2018 |
Kenessey I, Kramer Z, István L, Cserepes MT, Garay T, Hegedűs B, Dobos J, Tímár J, Tóvári J. Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model. Melanoma Research. PMID 30124539 DOI: 10.1097/Cmr.0000000000000488 |
0.644 |
|
| 2018 |
Timar J, Piurko V, Kenessey I, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Papai Z, Uhlyarik A. EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E15548 |
0.338 |
|
| 2017 |
Hegedüs L, Padányi R, Molnár J, Pászty K, Varga K, Kenessey I, Sárközy E, Wolf M, Grusch M, Hegyi Z, Homolya L, Aigner C, Garay T, Hegedüs B, Tímár J, et al. Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca(2+) Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK. Frontiers in Oncology. 7: 95. PMID 28596940 DOI: 10.3389/Fonc.2017.00095 |
0.424 |
|
| 2017 |
Tátrai E, Bartal A, Gacs A, Paku S, Kenessey I, Garay T, Hegedűs B, Molnár E, Cserepes MT, Hegedűs Z, Kucsma N, Szakács G, Tóvári J. Cell type-dependent HIF1 α-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumor cells. Oncotarget. PMID 28562340 DOI: 10.18632/Oncotarget.17806 |
0.652 |
|
| 2017 |
Kásler M, Ottó S, Kenessey I. [The current situation of cancer morbidity and mortality in the light of the National Cancer Registry]. Orvosi Hetilap. 158: 84-89. PMID 28110566 DOI: 10.1556/650.2017.30654 |
0.314 |
|
| 2017 |
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J, Fabian K, Kovalszky I, Kenessey I, Aigner C, Renyi-Vamos F, Klepetko W, Dome B, Hegedus B. KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Scientific Reports. 7: 39721. PMID 28051122 DOI: 10.1038/Srep39721 |
0.318 |
|
| 2016 |
Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, Dobos J, HegedÅ S B, Tóvári J, Tímár J. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Oncotarget. PMID 27780929 DOI: 10.18632/Oncotarget.12806 |
0.645 |
|
| 2016 |
Imrédi E, Tóth B, Doma V, Barbai T, Rásó E, Kenessey I, Tímár J. Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma. Melanoma Research. 26: 254-60. PMID 26848795 DOI: 10.1097/Cmr.0000000000000243 |
0.344 |
|
| 2015 |
Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, et al. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. The Journal of Pathology. PMID 26011651 DOI: 10.1002/Path.4567 |
0.413 |
|
| 2015 |
von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, ... ... Kenessey I, et al. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell. 27: 561-73. PMID 25843002 DOI: 10.1016/J.Ccell.2015.02.014 |
0.432 |
|
| 2015 |
Garay T, Kenessey I, Molnár E, Juhász É, Réti A, László V, Rózsás A, Dobos J, Döme B, Berger W, Klepetko W, Tóvári J, Tímár J, Heged?s B. Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells. Plos One. 10: e0117021. PMID 25646931 DOI: 10.1371/Journal.Pone.0117021 |
0.644 |
|
| 2015 |
Tökés AM, Szász AM, Geszti F, Lukács LV, Kenessey I, Turányi E, Meggyesházi N, Molnár IA, Fillinger J, Soltész I, Bálint K, Hanzély Z, Arató G, Szendröi M, Kulka J. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases. Journal of Clinical Pathology. 68: 274-82. PMID 25595275 DOI: 10.1136/Jclinpath-2014-202607 |
0.355 |
|
| 2015 |
Kenessey I, Kói K, Cserepes M, Dobos J, Hegedűs B, Tóvári J, Tímár J. Abstract 47: KRAS-mutation dependent effect of zoledronic acid in human NSCLC preclinical models Cancer Research. 75: 47-47. DOI: 10.1158/1538-7445.Am2015-47 |
0.671 |
|
| 2014 |
Tóvári J, Futosi K, Bartal A, Tátrai E, Gacs A, Kenessey I, Paku S. Boyden chamber-based method for characterizing the distribution of adhesions and cytoskeletal structure in HT1080 fibrosarcoma cells. Cell Adhesion & Migration. 8: 509-16. PMID 25482525 DOI: 10.4161/Cam.28734 |
0.57 |
|
| 2014 |
Lövey J, Nie D, Tóvári J, Kenessey I, Kandouz M, Tímár J, Kásler M, Honn KV. [Selective 12-lipoxygenase inhibition potentiates the effect of radiation on human prostate cancer cells in vitro and in vivo]. Magyar Onkologia. 58: 211-8. PMID 25260086 |
0.576 |
|
| 2014 |
Schelch K, Hoda MA, Klikovits T, Münzker J, Ghanim B, Wagner C, Garay T, Laszlo V, Setinek U, Dome B, Filipits M, Pirker C, Heffeter P, Selzer E, Tovari J, ... ... Kenessey I, et al. Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy. American Journal of Respiratory and Critical Care Medicine. 190: 763-72. PMID 25188816 DOI: 10.1164/Rccm.201404-0658Oc |
0.608 |
|
| 2014 |
Illyes I, Tokes AM, Kovacs A, Szasz AM, Molnar BA, Molnar IA, Kaszas I, Baranyak Z, Laszlo Z, Kenessey I, Kulka J. In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement. Virchows Archiv : An International Journal of Pathology. 465: 15-24. PMID 24809673 DOI: 10.1007/S00428-014-1579-5 |
0.325 |
|
| 2014 |
Madaras L, Kovács KA, Szász AM, Kenessey I, Tőkés AM, Székely B, Baranyák Z, Kiss O, Dank M, Kulka J. Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study. Pathology Oncology Research : Por. 20: 581-90. PMID 24357159 DOI: 10.1007/S12253-013-9735-9 |
0.343 |
|
| 2014 |
Virág J, Kenessey I, Haberler C, Piurkó V, Bálint K, Döme B, Tímár J, Garami M, Hegedűs B. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors. Pathology Oncology Research : Por. 20: 417-26. PMID 24190638 DOI: 10.1007/S12253-013-9711-4 |
0.415 |
|
| 2014 |
Nelhűbel GA, Károly B, Szabó B, Lotz G, Kiss A, Tóvári J, Kenessey I. The prognostic role of claudins in head and neck squamous cell carcinomas. Pathology Oncology Research : Por. 20: 99-106. PMID 23856835 DOI: 10.1007/S12253-013-9665-6 |
0.622 |
|
| 2014 |
Garay T, Kenessey I, Laszlo V, Tovari J, Berger W, Kovacs L, Timar J, Hegedus B. Abstract B37: Prenylation inhibition induces cell death in NRAS mutant melanoma cells Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B37 |
0.64 |
|
| 2014 |
Tátrai E, Bartal A, Fehér Z, Farkas Á, Paku S, Kenessey I, Tóvári J. Abstract 4965: Hypoxia has different effects on proliferation, migration and metastasis of various types of tumor cells Cancer Research. 74: 4965-4965. DOI: 10.1158/1538-7445.Am2014-4965 |
0.651 |
|
| 2013 |
Rózsás A, Berta J, Rojkó L, Horváth LZ, Keszthelyi M, Kenessey I, László V, Berger W, Grusch M, Hoda MA, Török S, Klepetko W, Rényi-Vámos F, Hegedűs B, Döme B, et al. Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma. Plos One. 8: e77459. PMID 24155958 DOI: 10.1371/Journal.Pone.0077459 |
0.677 |
|
| 2013 |
Madaras L, Baranyák Z, Kulka J, Szász AM, Kovács A, Lan PH, Székely B, Dank M, Nagy T, Kiss O, Harsányi L, Barbai T, Kenessey I, T?kés AM. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients. Pathology Oncology Research : Por. 19: 723-9. PMID 23709114 DOI: 10.1007/S12253-013-9635-Z |
0.301 |
|
| 2013 |
Kovács KA, Hegedus B, Kenessey I, TÃmár J. Tumor type-specific and skin region-selective metastasis of human cancers: another example of the "seed and soil" hypothesis. Cancer Metastasis Reviews. 32: 493-9. PMID 23636347 DOI: 10.1007/S10555-013-9418-8 |
0.362 |
|
| 2013 |
Nemes K, Sebestyén A, Márk A, Hajdu M, Kenessey I, Sticz T, Nagy E, Barna G, Váradi Z, Kovács G, Kopper L, Csóka M. Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL). Plos One. 8: e59335. PMID 23573198 DOI: 10.1371/Journal.Pone.0059335 |
0.348 |
|
| 2013 |
Lövey J, Nie D, Tóvári J, Kenessey I, Tímár J, Kandouz M, Honn KV. Radiosensitivity of human prostate cancer cells can be modulated by inhibition of 12-lipoxygenase. Cancer Letters. 335: 495-501. PMID 23523613 DOI: 10.1016/J.Canlet.2013.03.012 |
0.63 |
|
| 2013 |
Kovács KA, Kenessey I, TÃmár J. Skin metastasis of internal cancers: a single institution experience. Pathology Oncology Research : Por. 19: 515-20. PMID 23468362 DOI: 10.1007/S12253-013-9611-7 |
0.325 |
|
| 2013 |
Borka K, Kenessey I, Hujber-Pichler R, Szűcs N, Rácz K, Bodoky G, Harsányi L, Tímár J. Prognostic Factors in Neuroendocrine Tumors of the Pancreas Pancreatology. 13: S82. DOI: 10.1016/J.Pan.2013.04.287 |
0.324 |
|
| 2012 |
Hoda MA, Münzker J, Ghanim B, Schelch K, Klikovits T, Laszlo V, Sahin E, Bedeir A, Lackner A, Dome B, Setinek U, Filipits M, Eisenbauer M, Kenessey I, Török S, et al. Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. British Journal of Cancer. 107: 1978-86. PMID 23169291 DOI: 10.1038/Bjc.2012.519 |
0.354 |
|
| 2012 |
Kenessey I, Bánki B, Márk A, Varga N, Tóvári J, Ladányi A, Rásó E, Tímár J. Revisiting CB1 receptor as drug target in human melanoma. Pathology Oncology Research : Por. 18: 857-66. PMID 22447182 DOI: 10.1007/S12253-012-9515-Y |
0.628 |
|
| 2012 |
Tokes AM, Szasz AM, Kenessey I, Lukacs L, Kulka J. 180 Aurora Kinase-A and Ki67 Expression in Primary Breast Carcinomas and Corresponding Distant Metastases European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)70248-4 |
0.309 |
|
| 2011 |
Törzsök P, Riesz P, Kenessey I, Székely E, Somorácz A, Nyirády P, Romics I, Schaff Z, Lotz G, Kiss A. Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 59: 1022-30. PMID 22043024 DOI: 10.1369/0022155411424606 |
0.409 |
|
| 2011 |
Kenessey I. [Study of motogenic signal in human melanoma cells]. Magyar Onkologia. 55: 55-8. PMID 21617791 |
0.385 |
|
| 2011 |
Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, Tóvári J. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncology. 47: 487-96. PMID 21498106 DOI: 10.1016/J.Oraloncology.2011.03.020 |
0.613 |
|
| 2011 |
Dobos J, Kenessey I, Tímár J, Ladányi A. Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells. Pathology Oncology Research : Por. 17: 729-34. PMID 21455635 DOI: 10.1007/S12253-011-9377-8 |
0.469 |
|
| 2011 |
Mátrai Z, Tóth L, Szentirmay Z, Vámos FR, Klepetko W, Vadász P, Kenessey I, Kásler M. Sporadic desmoid tumors of the chest: long-term follow-up of 28 multimodally treated patients. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 40: 1170-6. PMID 21435893 DOI: 10.1016/J.Ejcts.2011.02.014 |
0.302 |
|
| 2010 |
Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1120-9. PMID 20581707 DOI: 10.1097/Jto.0B013E3181E2C1Ff |
0.654 |
|
| 2010 |
Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, et al. Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Current Cancer Drug Targets. 10: 332-42. PMID 20370683 DOI: 10.2174/156800910791190184 |
0.651 |
|
| 2010 |
Székely B, Madaras L, Szentmártoni G, Szász AM, Baranyák Z, Szittya L, Torgyík L, Zergényi E, Borbényi E, Kenessey I, Korompay A, Langmár Z, Bánhidy F, Kulka J, Dank M. [Comparison of breast cancer in young and old women based on clinicopathological features]. Magyar Onkologia. 54: 19-26. PMID 20350864 DOI: 10.1556/Monkol.54.2010.1.3 |
0.332 |
|
| 2009 |
Kulka J, Tokés AM, Tóth AI, Szász AM, Farkas A, Borka K, Járay B, Székely E, Istók R, Lotz G, Madaras L, Korompay A, Harsányi L, László Z, Rusz Z, ... ... Kenessey I, et al. [Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy]. Magyar Onkologia. 53: 335-43. PMID 20071305 DOI: 10.1556/Monkol.53.2009.4.2 |
0.355 |
|
| 2009 |
Kenessey I, Simon E, Futosi K, Bereczky B, Kiss A, Erdödi F, Gallagher JT, Tímár J, Tóvári J. Antimigratory and antimetastatic effect of heparin-derived 4-18 unit oligosaccharides in a preclinical human melanoma metastasis model. Thrombosis and Haemostasis. 102: 1265-73. PMID 19967160 DOI: 10.1160/Th09-01-0059 |
0.636 |
|
| 2009 |
Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1741-6. PMID 19240177 DOI: 10.1158/1078-0432.Ccr-08-1372 |
0.651 |
|
| 2009 |
Dome P, Teleki Z, Rihmer Z, Peter L, Dobos J, Kenessey I, Tovari J, Timar J, Paku S, Kovacs G, Dome B. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Molecular Psychiatry. 14: 523-31. PMID 18180758 DOI: 10.1038/Sj.Mp.4002138 |
0.56 |
|
| 2008 |
Lövey J, Bereczky B, Gilly R, Kenessey I, Rásó E, Simon E, Dobos J, Vágó A, Kásler M, Döme B, Tímár J, Tóvári J. Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 184: 1-7. PMID 18188516 DOI: 10.1007/S00066-008-1745-2 |
0.632 |
|
| 2007 |
Lövey J, Kenessey I, Rásó E, Dobos J, Vágó A, Kásler M, Futosi K, Döme B, Tímár J, Tóvári J. [Human recombinant erythropoietin-alpha increases the efficacy of irradiation in preclinical model]. Magyar Onkologia. 51: 53-61. PMID 17417676 |
0.588 |
|
| 2007 |
Deli T, Varga N, Adám A, Kenessey I, Rásó E, Puskás LG, Tóvári J, Fodor J, Fehér M, Szigeti GP, Csernoch L, Tímár J. Functional genomics of calcium channels in human melanoma cells. International Journal of Cancer. Journal International Du Cancer. 121: 55-65. PMID 17330843 DOI: 10.1002/Ijc.22621 |
0.58 |
|
| 2006 |
Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Research. 66: 7341-7. PMID 16849585 DOI: 10.1158/0008-5472.Can-05-4654 |
0.605 |
|
| 2005 |
Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7344-53. PMID 16243806 DOI: 10.1158/1078-0432.Ccr-05-1077 |
0.635 |
|
| Show low-probability matches. |